Literature DB >> 8167304

Defective clonal deletion and anergy induction in TCR transgenic lpr/lpr mice.

J D Mountz1, H Bluethmann, T Zhou, J Wu.   

Abstract

Although autoreactive T cells are thought to play a prominent role in autoimmune disease in MRL-lpr/lpr mice, it has been difficult to directly determine if autoreactive T cells escape from the thymus and react with self-antigens in the periphery. To identify a possible defect in clonal deletion or clonal anergy induction of auto-specific T cells, we have studied C57BL/6-lpr/lpr transgenic mouse expressing TCR genes that recognize a known self-antigen, the male H-Y antigen and analyzed clonal deletion and tolerance induction after neonatal tolerance induction with the class II MHC reactive superantigen staphylococcal enterotoxin B (SEB) in V beta 8 TCR transgenic and non-transgenic MRL-lpr/lpr mice. In lpr/lpr mice, the main defect was a thymic-dependent loss of self-tolerance by auto-specific T cells and also a small defect of clonal deletion of autoreactive thymocytes. Defective expression of the Fas apoptosis antigen results from the insertion of the ETn retrotransposon. The fas defect can be partially corrected in TCR-beta TCR transgenic mice in which accelerated T cell development prevents the lymphoproliferative disease and in CD2-fas transgenic mice in which fas expression is corrected in T cells. These results suggest that expression of the TCR-beta, fas and retrovirus genes are co-regulated during early thymocyte development, most likely by common enhancer transcription factors.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8167304     DOI: 10.1006/smim.1994.1005

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  6 in total

Review 1.  The Fas signaling connection between autoimmunity and embryonic lethality.

Authors:  H C Hsu; Y Matsuki; H G Zhang; T Zhou; J D Mountz
Journal:  J Clin Immunol       Date:  2001-01       Impact factor: 8.317

2.  Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression.

Authors:  L B Owen-Schaub; W Zhang; J C Cusack; L S Angelo; S M Santee; T Fujiwara; J A Roth; A B Deisseroth; W W Zhang; E Kruzel
Journal:  Mol Cell Biol       Date:  1995-06       Impact factor: 4.272

3.  T cells genetically engineered to overcome death signaling enhance adoptive cancer immunotherapy.

Authors:  Tori N Yamamoto; Ping-Hsien Lee; Suman K Vodnala; Devikala Gurusamy; Rigel J Kishton; Zhiya Yu; Arash Eidizadeh; Robert Eil; Jessica Fioravanti; Luca Gattinoni; James N Kochenderfer; Terry J Fry; Bulent Arman Aksoy; Jeffrey E Hammerbacher; Anthony C Cruz; Richard M Siegel; Nicholas P Restifo; Christopher A Klebanoff
Journal:  J Clin Invest       Date:  2019-02-25       Impact factor: 14.808

4.  Point mutations in the C-terminus of HIV-1 gp160 reduce apoptosis and calmodulin binding without affecting viral replication.

Authors:  Keith J Micoli; Olga Mamaeva; Sabine C Piller; Jennifer L Barker; George Pan; Eric Hunter; Jay M McDonald
Journal:  Virology       Date:  2005-10-17       Impact factor: 3.616

5.  Tolerance induction and endogenous regeneration of pancreatic beta-cells in established autoimmune diabetes.

Authors:  Charles Sia; Francoise Homo-Delarche
Journal:  Rev Diabet Stud       Date:  2005-02-10

6.  A role for Fas in negative selection of thymocytes in vivo.

Authors:  H Kishimoto; C D Surh; J Sprent
Journal:  J Exp Med       Date:  1998-05-04       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.